Joseph Newell's Insider Trades & SAST Disclosures
Joseph Newell's most recent trade in Atara Biotherapeutics Inc was a trade of 3,332 Common Stock done at an average price of $17.1 . Disclosure was reported to the exchange on Nov. 16, 2021.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Joseph Newell.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Atara Biotherapeutics Inc | Joseph Newell | Chief Operations Officer | Sale of securities on an exchange or to another person at price $ 17.12 per share. | 16 Nov 2021 | 3,332 | 113,097 (0%) | 0% | 17.1 | 57,034 | Common Stock |
| Atara Biotherapeutics Inc | Joseph Newell | Chief Operations Officer | Sale of securities on an exchange or to another person at price $ 17.71 per share. | 15 Nov 2021 | 7,000 | 116,429 (0%) | 0% | 17.7 | 124,004 | Common Stock |
| Atara Biotherapeutics Inc | Joseph Newell | Chief Operations Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.15 per share. | 15 Nov 2021 | 3,500 | 123,429 (0%) | 0% | 12.2 | 42,525 | Common Stock |
| Atara Biotherapeutics Inc | Joseph Newell | Chief Operations Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2021 | 2,792 | 32,083 | - | - | Employee Stock Option (Right to Buy) | |
| Atara Biotherapeutics Inc | Joseph Newell | Chief Operations Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2021 | 708 | 9,917 | - | - | Employee Stock Option (Right to Buy) | |
| Atara Biotherapeutics Inc | Joseph Newell | Chief Operations Officer | Sale of securities on an exchange or to another person at price $ 17.00 per share. | 22 Sep 2021 | 10,500 | 119,929 (0%) | 0% | 17 | 178,500 | Common Stock |
| Atara Biotherapeutics Inc | Joseph Newell | Chief Operations Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.15 per share. | 22 Sep 2021 | 10,500 | 130,429 (0%) | 0% | 12.2 | 127,575 | Common Stock |
| Atara Biotherapeutics Inc | Joseph Newell | Chief Operations Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Sep 2021 | 8,375 | 34,875 | - | - | Employee Stock Option (Right to Buy) | |
| Atara Biotherapeutics Inc | Joseph Newell | Chief Operations Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Sep 2021 | 2,125 | 10,625 | - | - | Employee Stock Option (Right to Buy) | |
| Atara Biotherapeutics Inc | Joseph Newell | Chief Operations Officer | Sale of securities on an exchange or to another person at price $ 15.61 per share. | 15 Sep 2021 | 3,116 | 119,929 (0%) | 0% | 15.6 | 48,647 | Common Stock |
| Atara Biotherapeutics Inc | Joseph Newell | Chief Operations Officer | Sale of securities on an exchange or to another person at price $ 15.00 per share. | 30 Aug 2021 | 3,500 | 123,045 (0%) | 0% | 15 | 52,500 | Common Stock |
| Atara Biotherapeutics Inc | Joseph Newell | Chief Operations Officer | Sale of securities on an exchange or to another person at price $ 12.53 per share. | 17 Aug 2021 | 2,426 | 126,545 (0%) | 0% | 12.5 | 30,403 | Common Stock |
| Atara Biotherapeutics Inc | Joseph Newell | Chief Operations Officer | Sale of securities on an exchange or to another person at price $ 14.55 per share. | 18 May 2021 | 2,453 | 128,971 (0%) | 0% | 14.5 | 35,691 | Common Stock |
| Atara Biotherapeutics Inc | Joseph Newell | Chief Operations Officer | Sale of securities on an exchange or to another person at price $ 15.00 per share. | 17 May 2021 | 3,500 | 131,424 (0%) | 0% | 15 | 52,500 | Common Stock |
| Atara Biotherapeutics Inc | Joseph Newell | Chief Operations Officer | Sale of securities on an exchange or to another person at price $ 14.74 per share. | 05 Apr 2021 | 655 | 134,924 (0%) | 0% | 14.7 | 9,655 | Common Stock |
| Atara Biotherapeutics Inc | Joseph Newell | Chief Operations Officer | Sale of securities on an exchange or to another person at price $ 14.58 per share. | 26 Mar 2021 | 2,640 | 135,579 (0%) | 0% | 14.6 | 38,491 | Common Stock |
| Atara Biotherapeutics Inc | Joseph Newell | Chief Operations Officer | Sale of securities on an exchange or to another person at price $ 17.41 per share. | 15 Mar 2021 | 7,000 | 138,219 (0%) | 0% | 17.4 | 121,870 | Common Stock |
| Atara Biotherapeutics Inc | Joseph Newell | Chief Operations Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.15 per share. | 15 Mar 2021 | 3,500 | 145,219 (0%) | 0% | 12.2 | 42,525 | Common Stock |
| Atara Biotherapeutics Inc | Joseph Newell | Chief Operations Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2021 | 2,791 | 43,250 | - | - | Employee Stock Option (Right to Buy) | |
| Atara Biotherapeutics Inc | Joseph Newell | Chief Operations Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2021 | 709 | 12,750 | - | - | Employee Stock Option (Right to Buy) | |
| Atara Biotherapeutics Inc | Joseph Newell | Chief Operations Officer | Sale of securities on an exchange or to another person at price $ 16.74 per share. | 02 Mar 2021 | 1,665 | 141,719 (0%) | 0% | 16.7 | 27,872 | Common Stock |
| Atara Biotherapeutics Inc | Joseph Newell | Chief Operations Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 56,929 | 56,929 | - | - | Employee Stock Option (Right to Buy) | |
| Atara Biotherapeutics Inc | Joseph Newell | Chief Operations Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 37,715 | 143,384 (0%) | 0% | 0 | Common Stock | |
| Atara Biotherapeutics Inc | Joseph Newell | Chief Operations Officer | Sale of securities on an exchange or to another person at price $ 20.39 per share. | 08 Feb 2021 | 3,886 | 105,669 (0%) | 0% | 20.4 | 79,236 | Common Stock |
| Atara Biotherapeutics Inc | Joseph Newell | Chief Operations Officer | Sale of securities on an exchange or to another person at price $ 18.84 per share. | 15 Jan 2021 | 7,000 | 109,555 (0%) | 0% | 18.8 | 131,880 | Common Stock |
| Atara Biotherapeutics Inc | Joseph Newell | Chief Operations Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.15 per share. | 15 Jan 2021 | 3,500 | 116,555 (0%) | 0% | 12.2 | 42,525 | Common Stock |
| Atara Biotherapeutics Inc | Joseph Newell | Chief Operations Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2021 | 3,146 | 46,041 | - | - | Employee Stock Option (Right to Buy) | |
| Atara Biotherapeutics Inc | Joseph Newell | Chief Operations Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2021 | 354 | 13,459 | - | - | Employee Stock Option (Right to Buy) | |
| Atara Biotherapeutics Inc | Joseph Newell | Chief Operations Officer | Sale of securities on an exchange or to another person at price $ 23.08 per share. | 16 Dec 2020 | 3,500 | 113,055 (0%) | 0% | 23.1 | 80,780 | Common Stock |
| Atara Biotherapeutics Inc | Joseph Newell | Chief Operations Officer | Sale of securities on an exchange or to another person at price $ 23.13 per share. | 16 Dec 2020 | 3,500 | 116,555 (0%) | 0% | 23.1 | 80,955 | Common Stock |
| Atara Biotherapeutics Inc | Joseph Newell | Chief Operations Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.15 per share. | 16 Dec 2020 | 3,500 | 120,055 (0%) | 0% | 12.2 | 42,525 | Common Stock |
| Atara Biotherapeutics Inc | Joseph Newell | Chief Operations Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Dec 2020 | 3,146 | 49,187 | - | - | Employee Stock Option (Right to Buy) | |
| Atara Biotherapeutics Inc | Joseph Newell | Chief Operations Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Dec 2020 | 354 | 13,813 | - | - | Employee Stock Option (Right to Buy) | |
| Atara Biotherapeutics Inc | Joseph Newell | Chief Operations Officer | Sale of securities on an exchange or to another person at price $ 19.77 per share. | 17 Nov 2020 | 1,648 | 116,555 (0%) | 0% | 19.8 | 32,588 | Common Stock |
| Atara Biotherapeutics Inc | Joseph Newell | Chief Operations Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Nov 2020 | 2,833 | 14,167 | - | - | Employee Stock Option (Right to Buy) | |
| Atara Biotherapeutics Inc | Joseph Newell | Chief Operations Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Nov 2020 | 667 | 52,333 | - | - | Employee Stock Option (Right to Buy) | |
| Atara Biotherapeutics Inc | Joseph Newell | Chief Operations Officer | Sale of securities on an exchange or to another person at price $ 12.09 per share. | 18 Aug 2020 | 1,678 | 122,203 (0%) | 0% | 12.1 | 20,287 | Common Stock |
| Atara Biotherapeutics Inc | Joseph Newell | Chief Operations Officer | Sale of securities on an exchange or to another person at price $ 11.22 per share. | 18 May 2020 | 1,603 | 123,881 (0%) | 0% | 11.2 | 17,986 | Common Stock |
| Atara Biotherapeutics Inc | Joseph Newell | Chief Operations Officer | Sale of securities on an exchange or to another person at price $ 7.94 per share. | 06 Apr 2020 | 657 | 125,484 (0%) | 0% | 7.9 | 5,217 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges